Zimmer Biomet Holdings Price to Book Ratio 2010-2025 | ZBH
Historical price to book ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years. The current price to book ratio for Zimmer Biomet Holdings as of May 23, 2025 is 1.46.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Zimmer Biomet Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-23 | 92.64 | 1.48 | |
| 2025-03-31 | 113.18 | $62.68 | 1.81 |
| 2024-12-31 | 105.40 | $62.66 | 1.68 |
| 2024-09-30 | 107.48 | $62.04 | 1.73 |
| 2024-06-30 | 107.82 | $62.22 | 1.73 |
| 2024-03-31 | 130.82 | $61.28 | 2.13 |
| 2023-12-31 | 120.40 | $60.74 | 1.98 |
| 2023-09-30 | 110.80 | $59.89 | 1.85 |
| 2023-06-30 | 143.45 | $59.28 | 2.42 |
| 2023-03-31 | 127.08 | $58.31 | 2.18 |
| 2022-12-31 | 125.17 | $57.55 | 2.18 |
| 2022-09-30 | 102.45 | $58.39 | 1.75 |
| 2022-06-30 | 102.72 | $57.85 | 1.78 |
| 2022-03-31 | 124.76 | $57.35 | 2.18 |
| 2021-12-31 | 119.99 | $60.60 | 1.98 |
| 2021-09-30 | 137.98 | $60.86 | 2.27 |
| 2021-06-30 | 151.37 | $60.29 | 2.51 |
| 2021-03-31 | 150.45 | $59.74 | 2.52 |
| 2020-12-31 | 144.60 | $58.76 | 2.46 |
| 2020-09-30 | 127.55 | $57.30 | 2.23 |
| 2020-06-30 | 111.63 | $56.28 | 1.98 |
| 2020-03-31 | 94.34 | $57.46 | 1.64 |
| 2019-12-31 | 139.35 | $60.16 | 2.32 |
| 2019-09-30 | 127.60 | $58.78 | 2.17 |
| 2019-06-30 | 109.25 | $56.92 | 1.92 |
| 2019-03-31 | 118.24 | $56.34 | 2.10 |
| 2018-12-31 | 95.86 | $55.28 | 1.73 |
| 2018-09-30 | 121.22 | $59.92 | 2.02 |
| 2018-06-30 | 102.56 | $59.21 | 1.73 |
| 2018-03-31 | 100.13 | $59.02 | 1.70 |
| 2017-12-31 | 110.57 | $57.92 | 1.91 |
| 2017-09-30 | 107.07 | $51.63 | 2.07 |
| 2017-06-30 | 117.17 | $50.86 | 2.30 |
| 2017-03-31 | 111.22 | $49.28 | 2.26 |
| 2016-12-31 | 93.81 | $48.20 | 1.95 |
| 2016-09-30 | 117.92 | $48.68 | 2.42 |
| 2016-06-30 | 108.96 | $47.82 | 2.28 |
| 2016-03-31 | 96.32 | $48.52 | 1.99 |
| 2015-12-31 | 92.46 | $48.79 | 1.90 |
| 2015-09-30 | 84.47 | $49.06 | 1.72 |
| 2015-06-30 | 98.00 | $49.81 | 1.97 |
| 2015-03-31 | 105.23 | $38.63 | 2.72 |
| 2014-12-31 | 101.37 | $38.61 | 2.63 |
| 2014-09-30 | 89.70 | $38.64 | 2.32 |
| 2014-06-30 | 92.45 | $38.22 | 2.42 |
| 2014-03-31 | 84.01 | $37.20 | 2.26 |
| 2013-12-31 | 82.58 | $37.10 | 2.23 |
| 2013-09-30 | 72.63 | $36.01 | 2.02 |
| 2013-06-30 | 66.11 | $34.83 | 1.90 |
| 2013-03-31 | 66.18 | $34.08 | 1.94 |
| 2012-12-31 | 58.49 | $34.19 | 1.71 |
| 2012-09-30 | 59.17 | $33.61 | 1.76 |
| 2012-06-30 | 56.17 | $32.72 | 1.72 |
| 2012-03-31 | 55.93 | $32.15 | 1.74 |
| 2011-12-31 | 46.35 | $30.98 | 1.50 |
| 2011-09-30 | 46.41 | $31.09 | 1.49 |
| 2011-06-30 | 54.84 | $31.60 | 1.74 |
| 2011-03-31 | 52.52 | $30.54 | 1.72 |
| 2010-12-31 | 46.58 | $29.51 | 1.58 |
| 2010-09-30 | 45.41 | $29.48 | 1.54 |
| 2010-06-30 | 46.90 | $28.46 | 1.65 |
| 2010-03-31 | 51.37 | $28.18 | 1.82 |
| 2009-12-31 | 51.29 | $27.61 | 1.86 |
| 2009-09-30 | 46.38 | $28.07 | 1.65 |
| 2009-06-30 | 36.97 | $27.09 | 1.36 |
| 2009-03-31 | 31.67 | $25.83 | 1.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.137B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.788B | 27.51 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $144.385B | 30.19 |
| EssilorLuxottica (ESLOY) | France | $135.514B | 0.00 |
| Medtronic (MDT) | Ireland | $103.771B | 14.71 |
| Haleon (HLN) | United Kingdom | $49.845B | 28.36 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.977B | 0.00 |
| ResMed (RMD) | United States | $35.996B | 27.04 |
| GE HealthCare Technologies (GEHC) | United States | $31.796B | 15.10 |
| Agilent Technologies (A) | United States | $31.270B | 20.66 |
| Terumo (TRUMY) | Japan | $27.864B | 36.19 |
| Insulet (PODD) | United States | $22.590B | 88.67 |
| Koninklijke Philips (PHG) | Netherlands | $21.684B | 15.59 |
| Baxter (BAX) | United States | $15.534B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.438B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.181B | 21.51 |
| Lantheus Holdings (LNTH) | United States | $5.172B | 13.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.201B | 18.77 |
| Perrigo (PRGO) | Ireland | $3.629B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Haemonetics (HAE) | United States | $3.178B | 14.48 |
| Envista Holdings (NVST) | United States | $2.859B | 23.76 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.788B | 39.96 |
| AtriCure (ATRC) | United States | $1.624B | 0.00 |
| Neogen (NEOG) | United States | $1.343B | 17.19 |
| Acuren (TIC) | United States | $1.288B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.206B | 12.25 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| Kestra Medical Technologies (KMTS) | United States | $1.145B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.933B | 11.93 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Evolus (EOLS) | United States | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.584B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.558B | 0.00 |
| Owens & Minor (OMI) | United States | $0.532B | 4.41 |
| Valneva SE (VALN) | France | $0.529B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.496B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.355B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 54.90 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.258B | 21.73 |
| Sanuwave Health (SNWV) | United States | $0.247B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.233B | 10.57 |
| Biote (BTMD) | United States | $0.205B | 5.77 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| OraSure Technologies (OSUR) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Agape ATP (ATPC) | $0.112B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.17 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |